Integrated Diagnostics Holding (IDH) aims to increase its revenues by 15 to 20% in 2022 through the analysis and radiology sectors.
Nancy Fahmy — Director of Investor Relations at the company — said that the global events resulting from the Russian-Ukrainian War will not affect the company’s expansion plan and that it continues its tireless search for investment opportunities in promising markets, especially since the need for the medical sector is increasing.
The profits of IDH declined by 34.2% during the first half (1H) of this year to reach EGP 439m, compared to a net profit of EGP 668.2m in 1H 2021.
The company’s revenues also fell to EGP 1.95bn, down from EGP 2.29bn.
Meanwhile, the parent company’s share of profits recorded EGP 422.2m, compared to EGP 646.4m.
Also, non-controlling equity recorded profits amounting to EGP 16.8m, compared to EGP 21.8m.